StockNews.AI
MURA
StockNews.AI
111 days

FORM 8.1(a) & (b) - Mural Oncology plc

1. Mural Oncology plc disclosed nil interests and short positions as of April 29. 2. Total ordinary shares held by directors amount to 43,622, representing 0.25%. 3. Directors' total share options account for 967,026 potential shares. 4. Mural is currently the offeree in an unidentified offer. 5. No agreements or arrangements to influence voting rights were reported.

7m saved
Insight
Article

FAQ

Why Neutral?

The opening position disclosure shows no significant interests, suggesting stability in current ownership.

How important is it?

The article reveals stability in Mural's share structure, crucial for investor confidence.

Why Short Term?

Since the disclosure directly relates to current holdings, its effects are immediate.

Related Companies

MURA
April 30, 2025 15:07 ET  | Source: Mural Oncology plc Ap9 FORM 8.1(a) & (b)(Opening Position Disclosure) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1.      KEY INFORMATION (a)   Full name of discloser:Mural Oncology plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offereeMural Oncology plc(d)   Is the discloser the offeror or the offeree?Offeree(e)   Date position held:The latest practicable date prior to the disclosure29 April 2025(f)   In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?If it is a cash offer or possible cash offer, state “N/A”N/A 2.      INTERESTS AND SHORT POSITIONS If there are interests and positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. Ap10 Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates (Note 1) Class of relevant security: (Note 2) InterestsShort positions Number%Number%(1)   Relevant securities owned and/or controlled:NIL-NIL-(2)   Cash-settled derivatives:NIL-NIL-(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell:NIL-NIL-Total:NIL-NIL- All interests and all short positions should be disclosed. Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. 3.      INTERESTS AND SHORT POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY MAKING THE DISCLOSURE   Details of any interests and short positions (including directors’ and other employee options) of any person acting in concert with the party making the disclosure:a)The directors of the Offeree detailed in the table below (together with their connected persons under Rule 3.3(b)(ii) of Part A of the Irish Takeover Rules) have the following interests in the OffereeDirectorClass of Relevant SecurityNumber of ordinary shares held at midnight on 29 April 2025Percentage of total issued share capital (rounded)Total number of ordinary shares underlying outstanding stock options, restricted share units and other subscription rightsCaroline LoewOrdinary shares of US$0.01 each43,6220.25% 865,908Scott JacksonOrdinary shares of US$0.01 eachꟷꟷ23,483Francis CussOrdinary shares of US$0.01 eachꟷꟷ23,483George Stanley GolumbeskiOrdinary shares of US$0.01 eachꟷꟷ15,334Benjamin HickeyOrdinary shares of US$0.01 eachꟷꟷ23,483Sachiyo MinegishiOrdinary shares of US$0.01 eachꟷꟷ15,335TOTAL-43,6220.25% 967,026 Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8. Ap11 4.      OTHER INFORMATION (a)      Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”None (b)      Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.None (c)      Attachments Is a Supplemental Form 8 attached?YES/NO No Date of disclosure:30 April 2025Contact name:Maiken Keson-BrookesTelephone number:+1 781 614 0239 Public disclosures under Rule 8.1 of the Rules must be made to a Regulatory Information Service. Ap12 NOTES ON FORM 8.1(a) and (b) 1.         See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) of Part B of the Rules. 2.         See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules. 3.      If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted. For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel. References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Related News